Table 3.
Details of PCI procedures in both groups
| Group I (n = 153) | Group II (n = 150) | X2 | P value | |
|---|---|---|---|---|
| Patients with LM stents | ||||
| N | 4 | 3 | 0.127 | 0.722 |
| % | 2.6% | 2% | ||
| Patients with SYNTAX score ≤ 22 | ||||
| N | 93 | 90 | 0.019 | 0.889 |
| % | 60.8% | 60% | ||
| Patients with SYNTAX score > 22 | ||||
| N | 60 | 69 | ||
| % | 39.2% | 40% | ||
| Patients with bifurcation stents | ||||
| N | 3 | 3 | 0.001 | 0.980 |
| % | 1.9% | 2% | ||
| Sirolimus eluting DES | ||||
| N | 125 | 121 | 0.053 | 0.818 |
| % | 81.7% | 80.7% | ||
| Non Sirolimus eluting DES | ||||
| N | 28 | 29 | ||
| % | 18.3% | 19.3% | ||
| Patients with overlapped stents | ||||
| N | 80 | 79 | 0.024 | 0.876 |
| % | 52.2% | 52.6% | ||
| Use of NC balloons for stent optimization | ||||
| N | 90 | 90 | 0.043 | 0.835 |
| % | 58.8% | 60% | ||
| Group I (n = 153) | Group II (n = 150) | T test | P value | |
|---|---|---|---|---|
| Length of stents in each patient (mm) | ||||
| Range | 12–133 | 15–132 | 0.829 | 0.373 |
| Mean ± SD | 45.29 ± 19.34 | 42.85 ± 18.16 | ||
| Amount of contrast used (ml) | ||||
| Range | 100–350 | 90–350 | − 1.345 | 0.180 |
| Mean ± SD | 151.91 ± 41.56 | 158.38 ± 56.28 | ||
LM left main, DES drug eluted stent, NC non-compliant